A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)
Clinical trial NCT03311555 · COMPLETED
Trial details
- NCT number
- NCT03311555
- Sponsor
- Andrew J. Armstrong, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2022-12-22
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.